Combination chemotherapy with or without s.c. IL-2 and IFN-α: results of a prospectively randomized trial of the Cooperative Advanced Malignant Melanoma Chemoimmunotherapy Group (ACIMM)-Reference-Cited by-同舟云学术

Combination chemotherapy with or without s.c. IL-2 and IFN-α: results of a prospectively randomized trial of the Cooperative Advanced Malignant Melanoma Chemoimmunotherapy Group (ACIMM)

Published:2002-01 Issue:2 Volume:86 Page:179-184
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Atzpodien J,Neuber K,Kamanabrou D,Fluck M,Bröcker E B,Neumann C,Rünger T M,Schuler G,von den Driesch P,Müller I,Paul E,Patzelt T,Reitz M

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/6600043.pdf

Reference21 articles.

1. Atkins MB, O'Boyle KR, Sosman JA, Weiß GR, Margolin KA, Ernest ML, Kappler K, Mier JW, Sparano JA, Fischer RI (1994) Multiinstitutional phase II trial of intensive combination chemoimmunotherapy for metastatic melanoma. J Clin Oncol 12: 1553–1560

2. Atzpodien J, Lopez Hänninen E, Kirchner H, Franzke A, Körfer A, Volkenandt M, Duensing S, Schomburg A, Chaitchik S, Poliwoda H (1995) Chemoimmunotherapy of advanced malignant melanoma: sequential administration of subcutaneous interleukin-2 and interferon-α after intravenous dacarbazine, cisplatin, carmustine and tamoxifen. Eur J Cancer 31: 876–881

3. Chiarion Sileni V, Nortilli R, Aversa SM, Paccagnella A, Medici M, Corti I, Favaretto AG, Cetto GL, Monfardini S (2001) Phase II randomized study of dacarbazine, carmustine, cisplatin and tamoxifen versus dacarbazine alone in advanced melanoma patients. Melanoma Res 11: 189–196

4. Creagan ET, Schaid DJ, Ahmann DL, Fryak S (1990) Disseminated malignant melanoma and recombinant interferon: analysis of seven consecutive phase II investigations. J Invest Dermatol 95: 6 Suppl 188–192

5. Falkson CI, Ibrahim J, Kirkwood JM (1998) Phase III of dacarbazine versus dacarbazine with interferon alpha-2b versus dacarbazine with tamoxifen versus dacarbazine with interferon alpha-2b and tamoxifen in patients with metastatic melanoma: an Eastern Cooperative Oncology Group study. J Clin Oncol 16: 1743–1751

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of drug dispersion on tumor-effector dynamics during combined chemo-immunotherapy with sensitivity analysis;Applied Mathematical Modelling;2024-10

2. Recurrence Patterns for Regionally Metastatic Melanoma Treated in the Era of Adjuvant Therapy: A Systematic Review and Meta-Analysis;Annals of Surgical Oncology;2022-12-07

3. Pulmonary metastasectomy in the era of targeted therapy and immunotherapy;Journal of Thoracic Disease;2021-04

4. The combination of encorafenib and binimetinib for the treatment of patients with BRAF-mutated advanced, unresectable, or metastatic melanoma: an update;Expert Review of Precision Medicine and Drug Development;2021-01-02

5. 3D in vitro cutaneous melanoma models;Biomaterials for 3D Tumor Modeling;2020